Mishani E - Search Results

1

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NM, Chisin R, Gazit A, Levitzki A, Mishani E. Bonasera TA, et al. Among authors: mishani e. Nucl Med Biol. 2001 May;28(4):359-74. doi: 10.1016/s0969-8051(01)00200-1. Nucl Med Biol. 2001. PMID: 11395308

2

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

Ortu G, Ben-David I, Rozen Y, Freedman NM, Chisin R, Levitzki A, Mishani E. Ortu G, et al. Among authors: mishani e. Int J Cancer. 2002 Oct 1;101(4):360-70. doi: 10.1002/ijc.10619. Int J Cancer. 2002. PMID: 12209961

3

Radiosynthesis of ML03, a novel positron emission tomography biomarker for targeting epidermal growth factor receptor via the labeling synthon: [11C]acryloyl chloride.

Ben-David I, Rozen Y, Ortu G, Mishani E. Ben-David I, et al. Among authors: mishani e. Appl Radiat Isot. 2003 Feb;58(2):209-17. doi: 10.1016/s0969-8043(02)00301-9. Appl Radiat Isot. 2003. PMID: 12573320

4

Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors.

Mishani E, Abourbeh G, Rozen Y, Jacobson O, Laky D, Ben David I, Levitzki A, Shaul M. Mishani E, et al. Nucl Med Biol. 2004 May;31(4):469-76. doi: 10.1016/j.nucmedbio.2003.12.005. Nucl Med Biol. 2004. PMID: 15093817

5

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.

Abourbeh G, Dissoki S, Jacobson O, Litchi A, Ben Daniel R, Laki D, Levitzki A, Mishani E. Abourbeh G, et al. Among authors: mishani e. Nucl Med Biol. 2007 Jan;34(1):55-70. doi: 10.1016/j.nucmedbio.2006.10.012. Nucl Med Biol. 2007. PMID: 17210462

6

Improved method for the quality assurance of [C-11]choline.

Mishani E, Ben-David I, Rozen Y. Mishani E, et al. Nucl Med Biol. 2002 Apr;29(3):359-62. doi: 10.1016/s0969-8051(01)00311-0. Nucl Med Biol. 2002. PMID: 11929707

7

Novel iodine-124 labeled EGFR inhibitors as potential PET agents for molecular imaging in cancer.

Shaul M, Abourbeh G, Jacobson O, Rozen Y, Laky D, Levitzki A, Mishani E. Shaul M, et al. Among authors: mishani e. Bioorg Med Chem. 2004 Jul 1;12(13):3421-9. doi: 10.1016/j.bmc.2004.04.044. Bioorg Med Chem. 2004. PMID: 15186828

8

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors.

Mishani E, Abourbeh G, Jacobson O, Dissoki S, Ben Daniel R, Rozen Y, Shaul M, Levitzki A. Mishani E, et al. J Med Chem. 2005 Aug 11;48(16):5337-48. doi: 10.1021/jm0580196. J Med Chem. 2005. PMID: 16078851

9

In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.

Freedman NM, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, Ehrlich D, Chisin R. Freedman NM, et al. Among authors: mishani e. J Nucl Med. 2005 Oct;46(10):1618-24. J Nucl Med. 2005. PMID: 16204711 Free article.

10

Tyrphostins and other tyrosine kinase inhibitors.

Levitzki A, Mishani E. Levitzki A, et al. Among authors: mishani e. Annu Rev Biochem. 2006;75:93-109. doi: 10.1146/annurev.biochem.75.103004.142657. Annu Rev Biochem. 2006. PMID: 16756486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters